The addition of E-cadherin function blocking antibodies sensitizes multicellular spheroids to treatment with various chemotherapeutic agents and E-cadherin-positive cells are more resistant to staurosporine-induced cell death than E-cadherin-negative breast cancer cells [20]. The gene discussed is CDH1; the disease is breast carcinoma.